Answers are grounded in this paper and cite their sources.
Latent class modeling identifies cognitive decline patterns in preclinical Alzheimer's, suggesting tailored trial designs.
Latent class modeling reveals substantial heterogeneity in preclinical trajectories with important implications for prevention trial design.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: